In 2005, the first GLP-1 got FDA approval to manage type 2 diabetes due to its ability to keep blood sugar stable, with others soon following
Significant differential metabolites in the three comparisons were PE-NMe2 (20:2(11Z,14Z)/15:0), PC (22:2(13Z,16Z)/12:0), L-Alloisoleucine, PS (O-18:0/13:0), Photinus Luciferin, 5beta-Cholestan-3alpha,4alpha,11beta,12beta,21-Pentol-3,21-Disulfate, Ixocarpanolide, 2-Piperidinone, PS [(18:2(9Z,12Z)/22:5(4Z,7Z,10Z
48 MichelP
The appropriate plan depends on your treatment response, side effects, blood sugar, weight history, and long-term health goals
Browser-only calculations Every number is worked out on your device